Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth et al. · Nature · 2015 · 1.2K citations · Full text

Epigenetic Silencing, Tumor Immunology, Cancer Immunosurveillance +7

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

David F. Stojdl, Brian D. Lichty, Benjamin R. tenOever et al. · Cancer Cell · 2003 · 841 citations · Full text

Pathogenesis, Immunology, Innate Immune System +7

Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis et al. · Immunity · 2019 · 676 citations · Full text

Tumor Biology, Oncology, Anti-pd-1 Therapy +11

Recombinant vesicular stomatitis viruses from DNA.

Nathan D. Lawson, Elizabeth A. Stillman, Michael A. Whitt et al. · Proceedings of the National Academy of Sciences · 1995 · 615 citations · Full text

Viral Replication, Synthetic Virology, Genetics +10

Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins

Vigo Heissmeyer, Fernando Macián, Sin‐Hyeog Im et al. · Nature Immunology · 2004 · 509 citations

Protein Function, Signal Transduction, Cytoskeleton +7